AP NEWS
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

GC Pharma Reports Q3 2019 Results

October 30, 2019 GMT

YONGIN, South Korea, Oct. 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended September 30, 2019.

Key Figures

Q3 2019(1)

Growth(1)

Total revenues

KRW 369.7 billion

+4.9%

Operating profit

KRW 36.6 billion

+30.6%

K-IFRS profit after taxation

KRW 22.4 billion

+41.7%

(1) Results and percentages compare to equivalent 2018 period.

Financial Highlights

About GC Pharma

GC Pharma is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions more than half a century. Green Cross Corporation updates its corporate brand as GC Pharma in early 2018. Green Cross Corporation remains the company’s registered, legal name.

This release includes forward-looking statements, which express the current beliefs and expectations of GC Pharma’s management. Such statements speak only as of the date on which they are made and the company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

View original content: http://www.prnewswire.com/news-releases/gc-pharma-reports-q3-2019-results-300947949.html

SOURCE GC Pharma